ORCHPHARMA — Orchid Pharma Share News
0.000.00%
Last trade - 00:00- IN₹49.30bn
- IN₹51.52bn
- IN₹12.32bn
Brief: Orchid Pharma Sept-Quarter Consol Profit 272.4 Million Rupees
Brief: Orchid Pharma Says Sept-Quarter Consol Profit At 272.4 Million Rupees
Brief: Orchid Pharma Gets No-Objection Letters From BSE, NSE For Merging Dhanuka Laboratories Into Co
Brief: Orchid Pharma June-Quarter Consol Profit 293.5 Million Rupees
Brief: Orchid Pharma Reappointed Manish Dhanuka As MD
India's Orchid Pharma up on getting drug combination approval
Brief: Orchid Pharma Receives Dcgi Approval For Antibiotic Drug Combination Of Cefepime, Enmetazobactam
Brief: India's Orchid Pharma March-Quarter Consol Profit Falls
Brief: Orchid Pharma Says Got Tax Order Ascertaining Total Revenue Abstract Of 26.6 Million Rupees
Brief: Orchid Pharma Got GST Order With Total Tax Liability Of 13.2 Million Rupees
India's Orchid Pharma jumps to near 3-yr high as FDA clears UTI drug
Brief: Orchid Pharma’s ‘Exblifep’ Receives USFDA Approval
India's Orchid Pharma hits over 2-1/2-yr high on Q3 profit surge
Brief: Orchid Pharma Dec-Quarter Consol Profit Jumps
India's Orchid Pharma hits upper circuit on nod to antibiotic in Europe
Brief: Orchid Pharma Gets European Medicines Agency Approval For Exblifep
Nuvama initiates coverage on India's Orchid Pharma with 'buy'
India's Orchid Pharma surges after Investec sees 42.3% upside in 12 months
Brief: Orchid Pharma Says Approved Draft Scheme Of Amalgamation Between Dhanuka Labs, Co